Screener
Merck & Co. MRK Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Merck & Co. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The source filing: Merck & Co.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 4:11 PM EDT
- Fiscal quarter
- Q3 FY2028
- Calendar quarter
- Q3 2028
- Accession
- 0000310158-26-000212
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Deferred Income Taxes | 1,433 | 1,439 |
| Other Noncurrent Liabilities | 7,573 | 7,688 |
| Merck & Co., Inc. Stockholders’ Equity | ||
| Common stock, $0.50 par valueAuthorized - 6,500,000,000 sharesIssued - 3,577,103,522 shares in 2026 and 2025 | 1,788 | 1,788 |
| Other paid-in capital | 44,950 | 45,029 |
| Retained earnings | 63,269 | 73,075 |
| Accumulated other comprehensive loss | (3,942) | (4,287) |
| 106,065 | 115,605 |
Item 1. Financial Statements
FAQ
- What is Merck & Co.'s common stock?
- Merck & Co. (MRK) reported common stock of 6.5B in Q2 2026.
- How has Merck & Co.'s common stock changed year-over-year?
- Merck & Co.'s common stock decreased by 0.0% year-over-year, from 6.5B to 6.5B.
- What is the long-term trend for Merck & Co.'s common stock?
- Over 5 years (2020 to 2025), Merck & Co.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 6.5B to 6.5B.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Merck & Co.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude